Question special
Lead Moderator

Thank you all for the nice introduction to the different systems currently available or under development. I would like to turn our discussion to the relative or absolute advantages of a “bihormonal bionic pancreas” over a “unihormonal bionic pancreas”. Are there particular groups of patients for whom the biohormonal bionic pancreas offers clear advantages over the unihormonal systems? Can we get the panelists' insights on the pros and cons of these two approaches?